Aquarius Surgical Technologies, the exclusive provider of a disruptive surgical laser system in the field of urology, has forged a strategic partnership with independent lessor Dext Capital.

Dext will launch a unique healthcare leasing solution for ASTI’s urology laser products, making them more accessible for prospective clients. Specifically, this solution provides clients with the capability of financing the acquisition of both the cutting-edge ASTI’s laser systems and the corresponding consumables.

“This distinctive and unprecedented financing solution significantly leverages our competitive advantage to increase future ASTI’s sales,” commented Gordon Willox, founder and president of ASTI. “Our clients will be able to allocate the required capital from their operating budget as opposed to the invariably limited traditional capital budget, giving them a greater probability to acquire ASTI’s technologies.”

Dext Capital is a privately-owned independent equipment finance company founded by a team of industry veterans with strong financial sponsorship from Sightway Capital, a Two Sigma company. As a direct non-bank lender, Dext Capital offers financial solutions to medical providers and manufacturers.

Aquarius Surgical Technologies is an exclusive provider of innovative, minimally invasive medical laser systems and consumables for multiple medical disciplines, principally in the field of urology. Solutions also include clinical education, service, support and maintenance.